Starpharma Holdings Limited (OTCMKTS:SPHRY – Get Free Report)’s stock price was up 15.7% during mid-day trading on Monday . The company traded as high as $0.87 and last traded at $0.87. Approximately 1,000 shares were traded during trading, a decline of 65% from the average daily volume of 2,822 shares. The stock had previously closed at $0.75.
Starpharma Stock Performance
The stock has a 50 day simple moving average of $0.86 and a 200-day simple moving average of $0.94.
About Starpharma
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.
Featured Articles
- Five stocks we like better than Starpharma
- The Significance of Brokerage Rankings in Stock Selection
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- What is the S&P/TSX Index?
- 3 Value Stocks You Can Buy Before They Become Big
- What Are Trending Stocks? Trending Stocks Explained
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.
